Marco Siccardi
About
Marco Siccardi is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Virology.
According to data from OpenAlex, Marco Siccardi has authored 147 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Infectious Diseases, 46 papers in Pediatrics, Perinatology and Child Health and 41 papers in Virology. Recurrent topics in Marco Siccardi's work include HIV/AIDS drug development and treatment (93 papers), HIV Research and Treatment (41 papers) and Pharmacological Effects and Toxicity Studies (39 papers). Marco Siccardi is often cited by papers focused on HIV/AIDS drug development and treatment (93 papers), HIV Research and Treatment (41 papers) and Pharmacological Effects and Toxicity Studies (39 papers). Marco Siccardi collaborates with scholars based in United Kingdom, Italy and United States. Marco Siccardi's co-authors include Andrew Owen, Antonio D’Avolio, Giovanni Di Perri, David Back, Lorena Baietto, Stefano Bonora, Mauro Sciandra, Darren Moss, Saye Khoo and Marco Simiele and has published in prestigious journals such as Nature Communications, Advanced Drug Delivery Reviews and Clinical Infectious Diseases.
In The Last Decade
Marco Siccardi
145 papers receiving 3.5k citations
Peers
Marco Siccardi
Richard C. Brundage United States
G. Richard Granneman United States
Yu Lou United States
Chantal Csajka Switzerland
Antonio D’Avolio Italy
Keith Gallicano Canada
Lubbe Wiesner South Africa
Richard M. W. Hoetelmans Netherlands
Marta Boffito United Kingdom
James J. Keirns United States
Citations per year, relative to Marco Siccardi Marco Siccardi (= 1×)
peers
Richard C. Brundage
Countries citing papers authored by Marco Siccardi
Since
Specialization
Citations
This map shows the geographic impact of Marco Siccardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Siccardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Siccardi more than expected).
Fields of papers citing papers by Marco Siccardi
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Marco Siccardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Siccardi. The network helps show where Marco Siccardi may publish in the future.
Co-authorship network of co-authors of Marco Siccardi
This figure shows the co-authorship network connecting the top 25 collaborators of Marco Siccardi. A scholar is included among the top collaborators of Marco Siccardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Siccardi. Marco Siccardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Montanha, Maiara Camotti, Catherine Orrell, Henry Mugerwa, et al.. (2024). Physiologically based pharmacokinetic modeling of drug–drug interactions between ritonavir‐boosted atazanavir and rifampicin in pregnancy. CPT Pharmacometrics & Systems Pharmacology. 13(11). 1967–1977.
2.
Montanha, Maiara Camotti, et al.. (2024). Physiologically‐based pharmacokinetic modelling of long‐acting injectable cabotegravir and rilpivirine in pregnancy. British Journal of Clinical Pharmacology. 91(4). 989–1002.
3.
Cirrincione, Lauren R., Catherine A. Chappell, Pauline Byakika‐Kibwika, et al.. (2023). Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: The DoubLNG pharmacokinetic study. Contraception. 122. 109975–109975.
4.
Mugerwa, Henry, Marco Siccardi, Maiara Camotti Montanha, et al.. (2023). Pharmacokinetics and Safety of Twice-daily Ritonavir-boosted Atazanavir With Rifampicin. Clinical Infectious Diseases. 78(5). 1246–1255.
5.
Rajoli, Rajith K. R., Henry Pertinez, Lalitkumar K. Vora, et al.. (2023). Physiologically Based Pharmacokinetic Modelling of Cabotegravir Microarray Patches in Rats and Humans. Pharmaceutics. 15(12). 2709–2709.
6.
Chappell, Catherine A., Pauline Byakika‐Kibwika, Julian Kaboggoza, et al.. (2022). Pharmacokinetics of levonorgestrel and etonogestrel contraceptive implants over 48 weeks with rilpivirine- or darunavir-based antiretroviral therapy. Journal of Antimicrobial Chemotherapy. 77(11). 3144–3152.
7.
Montanha, Maiara Camotti, et al.. (2022). A physiologically based pharmacokinetic model to predict pegylated liposomal doxorubicin disposition in rats and human. Drug Delivery and Translational Research. 12(9). 2178–2186.
8.
Halamoda‐Kenzaoui, Blanka, Rob J. Vandebriel, Marco Siccardi, et al.. (2021). Methodological needs in the quality and safety characterisation of nanotechnology-based health products: Priorities for method development and standardisation. Journal of Controlled Release. 336. 192–206.
9.
Giardiello, Marco, Neill J. Liptrott, Tom O. McDonald, et al.. (2016). Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies. Nature Communications. 7(1). 13184–13184.
10.
Alfirevic, Ana, Jill Durocher, David Dickens, et al.. (2015). Misoprostol-Induced Fever and Genetic Polymorphisms in Drug Transporters SLCO1B1 and ABCC4 in Women of Latin American and European Ancestry. Pharmacogenomics. 16(9). 919–928.
11.
Bonora, Stefano, Stefano Rusconi, Andrea Calcagno, et al.. (2015). Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study). Journal of Antimicrobial Chemotherapy. 70(11). 3096–3099.
12.
Dickinson, Laura, Alan Winston, Marta Boffito, et al.. (2014). Simulation of the impact of rifampicin on darunavir/ritonavir PK and dose adjustment strategies in HIV‐infected patients: a population PK approach. Journal of the International AIDS Society. 17(4S3). 19586–19586.
13.
Olagunju, Adeniyi, Alessandro Schipani, Marco Siccardi, et al.. (2014). CYP3A4*22 (c.522-191 C>T; rs35599367) is associated with lopinavir pharmacokinetics in HIV-positive adults. Pharmacogenetics and Genomics. 24(9). 459–463.
14.
Schipani, Alessandro, David Back, Andrew Owen, et al.. (2014). Use of In Vitro to In Vivo Extrapolation to Predict the Optimal Strategy for Patients Switching from Efavirenz to Maraviroc or Nevirapine. Clinical Pharmacokinetics. 54(1). 107–116.
15.
Siccardi, Marco, Catia Marzolini, Kay Seden, et al.. (2013). Prediction of drug-drug Interactions Between Various Antidepressants and Efavirenz or Boosted Protease Inhibitors Using a Physiologically Based Pharmacokinetic Modelling Approach. Clinical Pharmacokinetics. 52(7). 583–592.
16.
Siccardi, Marco, Adeniyi Olagunju, Kay Seden, et al.. (2013). Use of a physiologically-based pharmacokinetic model to simulate artemether dose adjustment for overcoming the drug-drug interaction with efavirenz. In Silico Pharmacology. 1(1). 4–4.
17.
D’Avolio, Antonio, Marco Simiele, Andrea Calcagno, et al.. (2012). Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells. Journal of Antimicrobial Chemotherapy. 68(4). 907–910.
18.
Cortés, Claudia P., et al.. (2012). Correlates of Efavirenz Exposure in Chilean Patients Affected With Human Immunodeficiency Virus Reveals a Novel Association With a Polymorphism in the Constitutive Androstane Receptor. Therapeutic Drug Monitoring. 35(1). 78–83.
19.
Else, Laura, Akil Jackson, Rebekah Puls, et al.. (2011). Pharmacokinetics of Lamivudine and Lamivudine-Triphosphate after Administration of 300 Milligrams and 150 Milligrams Once Daily to Healthy Volunteers: Results of the ENCORE 2 Study. Antimicrobial Agents and Chemotherapy. 56(3). 1427–1433.
20.
Garazzino, Silvia, Alessandro Aprato, Lorena Baietto, et al.. (2011). Ceftriaxone bone penetration in patients with septic non-union of the tibia. International Journal of Infectious Diseases. 15(6). e415–e421.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Richard C. Brundage Breakdown of academic impact, for papers by G. Richard Granneman Breakdown of academic impact, for papers by Yu Lou Breakdown of academic impact, for papers by Chantal Csajka Breakdown of academic impact, for papers by Antonio D’Avolio Breakdown of academic impact, for papers by Keith Gallicano Breakdown of academic impact, for papers by Lubbe Wiesner Breakdown of academic impact, for papers by Richard M. W. Hoetelmans Breakdown of academic impact, for papers by Marta Boffito Breakdown of academic impact, for papers by James J. Keirns